Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal
The collaboration focuses on SanegeneBio’s RNAi platform, featuring new chemistries and delivery technologies for siRNA medicines. Credit: luchschenF / Shutterstock.com.
The collaboration focuses on SanegeneBio’s RNAi platform, featuring new chemistries and delivery technologies for siRNA medicines. Credit: luchschenF / Shutterstock.com.